Acute Disseminated Encephalomyelitis Clinical Trials

7 recruiting

Acute Disseminated Encephalomyelitis Trials at a Glance

7 actively recruiting trials for acute disseminated encephalomyelitis are listed on ClinicalTrialsFinder across 6 cities in 3 countries. The largest study group is Not Applicable with 3 trials, with the heaviest enrollment activity in Beijing, Basel, and Angers. Lead sponsors running acute disseminated encephalomyelitis studies include Tongji Hospital, Xuanwu Hospital, Beijing, and Beijing Tiantan Hospital.

Browse acute disseminated encephalomyelitis trials by phase

Treatments under study

About Acute Disseminated Encephalomyelitis Clinical Trials

Looking for clinical trials for Acute Disseminated Encephalomyelitis? There are currently 7 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Acute Disseminated Encephalomyelitis trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Acute Disseminated Encephalomyelitis clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting
Not Applicable

High-throughput Omic Technology for Identification of Biomarkers of Relapsing Acute Disseminated Encephalomyelitis in Immune Cell Network

Acute Disseminated EncephalomyelitisEncephalitis Autoimmune
University Hospital, Angers20 enrolled8 locationsNCT06863974
Recruiting
Not Applicable

Assessment of Transcranial Alternating Current Stimulation's Clinical Efficacy in Treating Cognitive Impairment of Idiopathic Inflammatory Demyelinating Diseases

Acute Disseminated EncephalomyelitisMS (Multiple Sclerosis)Transcranial Alternating Current Stimulation+2 more
Xuanwu Hospital, Beijing128 enrolled1 locationNCT07087873
Recruiting

Swiss Pediatric Inflammatory Brain Disease Registry (Swiss-Ped-IBrainD)

Multiple SclerosisOptic NeuritisTransverse Myelitis+15 more
University of Bern500 enrolled13 locationsNCT05017142
Recruiting

Biomarkers in Autoimmune Disease of Nervous System

Myasthenia GravisAutoimmune EncephalitisMultiple Sclerosis+8 more
Tongji Hospital50,000 enrolled1 locationNCT06502015
Recruiting
Not Applicable

Efficacy and Safety of Calculus Bovis Sativus (CBS) for Idiopathic Inflammatory Demyelinating Disease (CBSinIIDD)

Multiple SclerosisAcute Disseminated EncephalomyelitisNeuromyelitis Optica Spectrum Disorder+2 more
Tongji Hospital250 enrolled1 locationNCT06474520
Recruiting

National, Multicentric Registry Study on Neuroimmunological Diseases in China

Myasthenia GravisAutoimmune EncephalitisMultiple Sclerosis+3 more
Xuanwu Hospital, Beijing7,000 enrolled1 locationNCT06443333
Recruiting

China National Registry of Neuro-Inflammatory Diseases

Multiple SclerosisClinically Isolated SyndromeAcute Disseminated Encephalomyelitis+4 more
Beijing Tiantan Hospital10,000 enrolled1 locationNCT05154370